Abstract
In vitro susceptibilities of Rickettsia rickettsii and Rickettsia conorii to roxithromycin, pristinamycin, and the pristinamycin compounds, P1 and P2, were determined by a dye uptake assay and a plaque assay. The MICs were 1 microgram/ml for roxithromycin, 2 micrograms/ml for pristinamycin, greater than 256 micrograms/ml for P1, and 2 micrograms/ml for P2. Compounds P1 and P2 did not share synergetic activity. The toxicity of each compound was determined by a dye uptake assay. Toxic concentrations were 128 micrograms/ml for roxithromycin, 32 micrograms/ml for pristinamycin, greater than 256 micrograms/ml for P1, and 32 micrograms/ml for P2. Roxithromycin and pristinamycin could be useful in the treatment of Rocky Mountain spotted fever and Mediterranean spotted fever.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bertrand A., Janbon F., Jonquet O., Reynes J. Infections par les rickettsiales et fluoroquinolones. Pathol Biol (Paris) 1988 May;36(5):493–495. [PubMed] [Google Scholar]
- Helmick C. G., Bernard K. W., D'Angelo L. J. Rocky Mountain spotted fever: clinical, laboratory, and epidemiological features of 262 cases. J Infect Dis. 1984 Oct;150(4):480–488. doi: 10.1093/infdis/150.4.480. [DOI] [PubMed] [Google Scholar]
- Le Goffic F. Structure activity relationships in lincosamide and streptogramin antibiotics. J Antimicrob Chemother. 1985 Jul;16 (Suppl A):13–21. doi: 10.1093/jac/16.suppl_a.13. [DOI] [PubMed] [Google Scholar]
- Muñoz-Espin T., López-Parés P., Espejo-Arenas E., Font-Creus B., Martinez-Vila I., Travería-Casanova J., Segura-Porta F., Bella-Cueto F. Erythromycin versus tetracycline for treatment of Mediterranean spotted fever. Arch Dis Child. 1986 Oct;61(10):1027–1029. doi: 10.1136/adc.61.10.1027. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Raoult D., Roussellier P., Galicher V., Perez R., Tamalet J. In vitro susceptibility of Rickettsia conorii to ciprofloxacin as determined by suppressing lethality in chicken embryos and by plaque assay. Antimicrob Agents Chemother. 1986 Mar;29(3):424–425. doi: 10.1128/aac.29.3.424. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Raoult D., Roussellier P., Tamalet J. In vitro evaluation of josamycin, spiramycin, and erythromycin against Rickettsia rickettsii and R. conorii. Antimicrob Agents Chemother. 1988 Feb;32(2):255–256. doi: 10.1128/aac.32.2.255. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Raoult D., Roussellier P., Vestris G., Galicher V., Perez R., Tamalet J. Susceptibility of Rickettsia conorii and R. rickettsii to pefloxacin, in vitro and in ovo. J Antimicrob Chemother. 1987 Mar;19(3):303–305. doi: 10.1093/jac/19.3.303. [DOI] [PubMed] [Google Scholar]
- Raoult D., Roussellier P., Vestris G., Tamalet J. In vitro antibiotic susceptibility of Rickettsia rickettsii and Rickettsia conorii: plaque assay and microplaque colorimetric assay. J Infect Dis. 1987 May;155(5):1059–1062. doi: 10.1093/infdis/155.5.1059. [DOI] [PubMed] [Google Scholar]
- Wike D. A., Tallent G., Peacock M. G., Ormsbee R. A. Studies of the rickettsial plaque assay technique. Infect Immun. 1972 May;5(5):715–722. doi: 10.1128/iai.5.5.715-722.1972. [DOI] [PMC free article] [PubMed] [Google Scholar]